2 Biotechs Unveil Separate Fundings Totaling $325M

By Law360 Staff · March 20, 2024, 10:36 AM EDT

Life sciences companies Clasp Therapeutics and Cooley-advised Capstan Therapeutics, which develop treatments for a range of health conditions including cancer and autoimmune diseases, separately announced funding rounds Wednesday that together total...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login